Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Current Assets (2023 - 2025)

Profound Medical has reported Current Assets over the past 3 years, most recently at $76.1 million for Q4 2025.

  • Quarterly results put Current Assets at $76.1 million for Q4 2025, up 10.17% from a year ago — trailing twelve months through Dec 2025 was $76.1 million (up 10.17% YoY), and the annual figure for FY2025 was $76.1 million, up 10.17%.
  • Current Assets for Q4 2025 was $76.1 million at Profound Medical, up from $41.5 million in the prior quarter.
  • Over the last five years, Current Assets for PROF hit a ceiling of $76.1 million in Q4 2025 and a floor of $41.5 million in Q3 2025.
  • Median Current Assets over the past 3 years was $54.4 million (2025), compared with a mean of $56.2 million.
  • Biggest five-year swings in Current Assets: skyrocketed 64.85% in 2024 and later increased 10.17% in 2025.
  • Profound Medical's Current Assets stood at $41.9 million in 2023, then skyrocketed by 64.85% to $69.1 million in 2024, then rose by 10.17% to $76.1 million in 2025.
  • The last three reported values for Current Assets were $76.1 million (Q4 2025), $41.5 million (Q3 2025), and $48.8 million (Q2 2025) per Business Quant data.